<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:06:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9163185" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9163185</identifier>
        <datestamp>2022-06-05</datestamp>
        <setSpec>nutd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Nutr Diabetes</journal-id>
              <journal-id journal-id-type="iso-abbrev">Nutr Diabetes</journal-id>
              <journal-title-group>
                <journal-title>Nutrition &amp; Diabetes</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2044-4052</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9163185</article-id>
              <article-id pub-id-type="pmcid">PMC9163185</article-id>
              <article-id pub-id-type="pmc-uid">9163185</article-id>
              <article-id pub-id-type="pmid">35654771</article-id>
              <article-id pub-id-type="publisher-id">207</article-id>
              <article-id pub-id-type="doi">10.1038/s41387-022-00207-1</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Changes in adiponectin:leptin ratio among older adults with obesity following a 12-month exercise and diet intervention</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1711-398X</contrib-id>
                  <name>
                    <surname>Senkus</surname>
                    <given-names>Katelyn E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2497-4582</contrib-id>
                  <name>
                    <surname>Crowe-White</surname>
                    <given-names>Kristi M.</given-names>
                  </name>
                  <address>
                    <email>kcrowe@ches.ua.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bolland</surname>
                    <given-names>Anneliese C.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Locher</surname>
                    <given-names>Julie L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ard</surname>
                    <given-names>Jamy D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411015.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0727 7545</institution-id><institution>Department of Human Nutrition, </institution><institution>The University of Alabama, </institution></institution-wrap>Tuscaloosa, AL USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411015.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0727 7545</institution-id><institution>College of Communication and Information Sciences, Communication Studies &amp; Institute for Communication and Information Research, </institution><institution>The University of Alabama, </institution></institution-wrap>Tuscaloosa, AL USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.265892.2</institution-id><institution-id institution-id-type="ISNI">0000000106344187</institution-id><institution>Division of Gerontology, Geriatrics and Palliative Care, Department of Medicine, </institution><institution>University of Alabama at Birmingham, </institution></institution-wrap>Birmingham, AL USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.241167.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2185 3318</institution-id><institution>Wake Forest University School of Medicine, Department of Epidemiology and Prevention, </institution></institution-wrap>Winston-Salem, NC USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>2</day>
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>2</day>
                <month>6</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>12</volume>
              <elocation-id>30</elocation-id>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>25</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Excess adiposity is characterized by alterations in adipokine secretion such that circulating leptin concentrations are increased with reductions in adiponectin. An emerging biomarker for the assessment of this adipose tissue (AT) dysfunction is the adiponectin:leptin (AL) ratio. A low AL ratio may be suggestive of dysfunctional AT and, consequently, a heightened cardiometabolic disease risk. This ancillary study investigated the relationship between the AL ratio and cardiometabolic health among community-dwelling older adults with obesity, as well as the effects of a 12-month exercise and diet intervention on changes in the AL ratio.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Participants (<italic>n</italic> = 163, 70.2 ± 4.7 years, 38.0% male) were randomized to the exercise only group, exercise + nutrient-dense weight maintenance group (exercise + weight maintenance), or exercise + nutrient-dense caloric restriction of 500 kcal/d group (exercise + intentional weight loss) (clinicaltrials.gov #NCT00955903). Total and regional adiposity as determined by magnetic resonance imaging (MRI) and dual-energy X-ray absorptiometry (DXA), anthropometrics, and cardiometabolic biomarkers were assessed at baseline and 12 months.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">The AL ratio was significantly (<italic>p</italic> &lt; 0.05) inversely correlated with body mass index, waist circumference, measures of adiposity, and insulin among all participants at baseline. Among females only, significant positive and inverse correlations were also observed between this ratio and high-density lipoprotein cholesterol and the inflammatory biomarkers high sensitivity C-reactive protein and interleukin-6, respectively. While controlling for biological sex, a significant time by intervention group interaction effect (<italic>p</italic> &lt; 0.05) was observed such that the AL ratio significantly increased from baseline to study completion among participants in the exercise + weight maintenance group and exercise + intentional weight loss group. Post hoc analysis revealed that the exercise + intentional weight loss group exhibited a significantly greater AL ratio at study completion compared to other groups (<italic>p</italic> &lt; 0.05 all).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">Results are in support of the AL ratio as a measure of AT dysfunction among older adults. Furthermore, results suggest that a 12-month exercise and diet intervention with intentional weight loss assists in improving the AL ratio in this population.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Risk factors</kwd>
                <kwd>Translational research</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1" sec-type="introduction">
              <title>Introduction</title>
              <p id="Par5">Obesity, a multifactorial disease characterized by excess adiposity, has been associated with increased cardiometabolic disease risk [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. This connection stems in part from the endocrine function of adipose tissue such that adipocyte-derived secretory factors, known as adipokines, influence systemic health [<xref ref-type="bibr" rid="CR3">3</xref>]. Among several identified adipokines, leptin and adiponectin have garnered much attention due to the prominent role each plays in maintaining metabolic homeostasis. Leptin regulates food intake as well as energy expenditure, and it can also stimulate the production of pro-inflammatory cytokines [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In contrast, adiponectin exhibits anti-inflammatory and anti-atherogenic activity with insulin-sensitizing properties [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>].</p>
              <p id="Par6">In obesity, adipose tissue undergoes accelerated cellular and structural remodeling to compensate for excessive energy intake [<xref ref-type="bibr" rid="CR8">8</xref>]. These adaptations detrimentally impact adipokine secretion such that circulating leptin increases with a concomitant reduction in adiponectin. The dysregulated expression of these adipokines results in adipose tissue dysfunction and, consequently, a disruption in metabolic homeostasis. With such alterations, cardiometabolic consequences are likely to ensue, including low-grade inflammation, insulin resistance, and dyslipidemia, among others [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
              <p id="Par7">An emerging biomarker for the assessment of adipose tissue dysfunction is the adiponectin:leptin (AL) ratio. Previous research suggests that compared to independent measures of these adipokines, this ratio more strongly correlates with inflammation, insulin resistance, and oxidative stress, as well as a number of cardiometabolic risk factors [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. As such, the AL ratio may be a practical measure for characterizing adipose tissue dysfunction and identifying individuals who are at an increased risk for cardiometabolic disease. Potential strategies to increase the AL ratio include weight loss, physical activity, and modifications to diet composition as these are related to an increase in adiponectin levels with a reduction in leptin levels [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
              <p id="Par8">Although research has demonstrated a strong relationship between AL ratio and adipose tissue dysfunction in adults, investigation of this relationship in an older adult population remains scarce. Furthermore, there is a paucity of intervention research evaluating the sensitivity of the AL ratio to lifestyle interventions. Considering this gap in the research, this ancillary study aimed to investigate the relationship between the AL ratio and cardiometabolic health among community-dwelling older adults with obesity and to assess the changes in AL ratio following a 12-month exercise and diet intervention. It was hypothesized that the AL ratio would be inversely related to adiposity and cardiometabolic biomarkers, including measures of insulin and glucose dynamics, lipids, and inflammation. Further, it was also hypothesized that an intervention combining exercise, diet quality improvements, and weight loss would result in the greatest improvement of AL ratio compared to similar lifestyle interventions without a weight loss component.</p>
            </sec>
            <sec id="Sec2" sec-type="materials|methods">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Participants</title>
                <p id="Par9">This study was ancillary to a randomized controlled trial investigating the effects of a 12-month exercise and diet intervention on body composition and functional status among community-dwelling adults 65 years and older with obesity (Calorie Restriction in Overweight SeniorS: Response of Older Adults to a Dieting Study, CROSSROADS study; ClinicalTrial.gov #NCT00955903) [<xref ref-type="bibr" rid="CR16">16</xref>]. By study design, participants were at risk for cardiometabolic disease with a body mass index (BMI) of 30–40 kg/m<sup>2</sup> and taking at least one medication to control lipids, blood pressure, or blood glucose. Participants were excluded if they had medical, physical, or psychiatric limitations that would prevent intervention adoption and/or confound lifestyle-related body weight changes. All protocols were approved by the Institutional Review Board at The University of Alabama at Birmingham and The University of Alabama, and written informed consent was obtained from all participants for the parent study and this ancillary analysis.</p>
              </sec>
              <sec id="Sec4">
                <title>Study design</title>
                <p id="Par10">Following stratification by age (65–74, 75+ years), biological sex, and race, participants were assigned to one of the three intervention groups using a block randomization scheme: 1. Exercise only, 2. Exercise + nutrient-dense weight maintenance (exercise + weight maintenance), or 3. Exercise + nutrient-dense caloric restriction of 500 kcal/d (exercise + weight loss). To minimize potential bias, study personnel involved in data collection were blinded to group assignment.</p>
                <p id="Par11">All participants followed a standard exercise program comprised of aerobic and resistance training with home-based and gym-based activities. An exercise scientist and trainer provided tailored recommendations to participants to support weekly aerobic and resistance training goals of 90–150 min of moderate-vigorous cardiovascular exercise and two resistance training sessions, respectively. While participants were not limited to specific cardiovascular exercises, a list of common exercises was provided and a discussion of new movements to incorporate took place during group counseling sessions. Resistance training exercises were completed using resistance bands and targeted major upper and lower extremity muscle groups. Participants were given heart rate monitors to monitor the integrity of exercise sessions. One of two resistance training sessions per week was overseen by a study team member and the remaining exercise was monitored using physical activity diaries and accelerometry.</p>
                <p id="Par12">Participants in the weight maintenance and weight loss groups received counseling by a registered dietitian nutritionist (RDN) to improve dietary quality with recommendations grounded in the time-calorie displacement theory [<xref ref-type="bibr" rid="CR17">17</xref>]. Counseling sessions were facilitated by the RDN weekly for the first six months and then every other week until study completion. Briefly, low-energy-dense fruits, vegetables, lean protein, and whole grains were encouraged with a target macronutrient intake of 25% calories from protein, 47% calories from carbohydrates, and 28% calories from fat. Both the weight maintenance and weight loss groups were given daily calorie goals based on estimates of total energy expenditure (TEE) obtained from the measured resting metabolic rate at baseline. Notably, daily calorie goals for participants in the weight loss group were 500 kcal/d less than the baseline TEE. The prescribed caloric restriction was consistent with safe weight loss recommendations for older adults outlined by the American Society for Nutrition and The Obesity Society [<xref ref-type="bibr" rid="CR18">18</xref>]. Adherence to dietary recommendations was assessed by three unannounced 24-h dietary recalls using a multi-pass interview approach. The nutrition data system for research (NDSR), a software program validated for use among older adults, was used to generate dietary intake data (Nutrition Coordinating Center, Minneapolis, MN, 2013) [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
              </sec>
              <sec id="Sec5">
                <title>Outcome measures</title>
                <p id="Par13">Fasting blood samples were obtained at baseline and 12 months, and the following cardiometabolic outcome measures were included in this ancillary analysis; insulin, glucose, lipids, and high sensitivity c-reactive protein (hsCRP) (turbidimetric assays using reagents from Pointe Scientific, Canton, MI and a SIRRIS analyzer, Stanbio Laboratory, Boerne, TX), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) (electrochemiluminescence, Meso Scale Discovery, Rockville, MD), as well as adiponectin and leptin (radioimmunoassay and RIA reagents, respectively, Millipore, St. Charles, MO). The AL ratio was determined using the following equation: (adiponectin (μg/mL)/leptin (ng/mL) [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
                <p id="Par14">Abdominal adipose tissue (intra-abdominal, subcutaneous, and total abdominal volume) was measured by magnetic resonance imaging using a 3-Tesla Phillips Achieva System (Philips, Andover, MA, USA) at the aforementioned time points. Fat mass (total and trunk) was quantified by dual-energy X-ray absorptiometry (DXA) using a Lunar DPX-L densitometer with body composition Adult Software Version 1.33 (Lunar Corp, Madison, WI, USA). Other outcomes related to body composition included BMI and waist circumference (WC).</p>
                <p id="Par15">Blood pressure was measured using automated blood pressure devices (Omron HEM 907-XL, Omron Healthcare, Kyoto, Japan) by trained study personnel. Assessments were conducted in duplicates measured 30 s apart and averaged. In addition, a detailed methodology of the parent study has been published elsewhere [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
              </sec>
              <sec id="Sec6">
                <title>Statistical analyses</title>
                <p id="Par16">Statistical analysis was performed using SAS 9.4 (SAS Institute, Cary, NC, USA). Variables with normal distributions are expressed as mean ± standard deviation (SD), whereas, variables with non-normal distributions are expressed as median [25th percentile, 75th percentile]. Mann-Whitney U-test and Spearman’s correlations were utilized to assess the relationship between AL ratio and cardiometabolic health at baseline. A generalized linear mixed model was estimated (SAS<sc>proc glimmix</sc>) using residual pseudo-likelihood to evaluate intervention effects on the AL ratio while controlling for biological sex. Given the heavily skewed right distribution of the AL ratio, it was modeled using a negative binomial error distribution with a log link function. The variance-covariance was allowed to be unstructured and parameterized through its Cholesky root. Degrees of freedom were determined using a containment method. Random effects were modeled based on <italic>R</italic>-side within-subject variance. Probabilities were adjusted using a method developed by Tukey and Kramer when more than two simultaneous post hoc comparisons were conducted [<xref ref-type="bibr" rid="CR21">21</xref>]. Statistical significance was defined as <italic>p</italic> &lt; 0.05.</p>
              </sec>
            </sec>
            <sec id="Sec7" sec-type="results">
              <title>Results</title>
              <sec id="Sec8">
                <title>Study participants</title>
                <p id="Par17">A total of 164 participants were enrolled in the CROSSROADS parent study. However, one participant did not have sufficient data to determine AL ratio and, thus, was excluded from this ancillary analysis (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Participants (<italic>N</italic> = 163, 70.2 ± 4.7 years, 38.0% male, 23.5% African American) were randomized to the exercise group (<italic>n</italic> = 53), the exercise + weight maintenance group (<italic>n</italic> = 55), or the exercise + weight loss group (<italic>n</italic> = 55). Of these, 147 participants completed the study (control: <italic>n</italic> = 51; weight maintenance: <italic>n</italic> = 47; weight loss: <italic>n</italic> = 49). Justification of attrition and compliance has been previously reported [<xref ref-type="bibr" rid="CR16">16</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><title>Flow Diagram for Study Inclusion.</title><p>Recruitment, randomization, and allocation of a 12-month exercise and diet intervention conducted among older adults with obesity.</p></caption><graphic xlink:href="41387_2022_207_Fig1_HTML" id="d32e481"/></fig></p>
                <p id="Par18">Participant characteristics are presented in Table <xref rid="Tab1" ref-type="table">1</xref>. A significant difference in AL ratio at baseline was observed between males and females (males: 0.33 [0.21, 0.61]; females: 0.19 [0.12, 0.29], <italic>p</italic> &lt; 0.001). As such, the correlational analyses were conducted separately by biological sex.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical and biochemical baseline characteristics among older adults with obesity following a 12-month exercise and diet intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>All participants (<italic>n</italic> = 163)</th><th>Males (<italic>n</italic> = 62)</th><th>Females (<italic>n</italic> = 101)</th></tr></thead><tbody><tr><td>Age (year)</td><td>70.2 ± 4.7</td><td>70.4 ± 4.7</td><td>70.1 ± 4.6</td></tr><tr><td>Male sex, no. (%)</td><td>62 (38.0)</td><td>–</td><td>–</td></tr><tr><td>Race/ethnicity, no (%)</td><td/><td/><td/></tr><tr><td> European American</td><td>124 (76.1)</td><td>55 (88.71)</td><td>69 (68.32)</td></tr><tr><td> African American</td><td>38 (23.3)</td><td>6 (9.68)</td><td>32 (31.68)</td></tr><tr><td> Asian</td><td>1 (0.6)</td><td>1 (1.61)</td><td>0 (0.00)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>33.6 ± 3.0</td><td>33.7 ± 3.1</td><td>33.6 ± 3.0</td></tr><tr><td>WC (in)</td><td>44 ± 4</td><td>47 ± 3</td><td>42 ± 4</td></tr><tr><td>IAAT (cm<sup>3</sup>)</td><td>3478.8 ± 1808.8</td><td>4932.1 ± 1887.3</td><td>2656.8 ± 1119.3</td></tr><tr><td>SAAT (cm<sup>3</sup>)</td><td>5244.9 ± 1717.2</td><td>4710.0 ± 1616.5</td><td>2580.0 (1847.0, 3164.0)</td></tr><tr><td>Tot Ab volume (cm<sup>3</sup>)</td><td>8689.9 ± 2467.2</td><td>9557.9 ± 2747.9</td><td>8198.9 ± 2157.1</td></tr><tr><td>DXA total fat tissue (%)</td><td>45.8 ± 6.1</td><td>39.9 ± 4.3</td><td>49.6 ± 3.6</td></tr><tr><td>DXA trunk fat tissue (%)</td><td>49.8 ± 5.4</td><td>46.3 ± 4.6</td><td>52.0 ± 4.6</td></tr><tr><td>Insulin (μU/mL)</td><td>13.4 (10.0, 19.8)</td><td>13.8 (9.6, 20.3)</td><td>13.3 (10.2, 19.8)</td></tr><tr><td>Glucose (mg/dL)</td><td>103.5 (94.0, 117.0)</td><td>106.0 (96.0, 122.0)</td><td>102.5 (94.0, 115.0)</td></tr><tr><td>Cholesterol (mg/dL)</td><td>178.7 ± 37.7</td><td>168.4 ± 35.7</td><td>185.0 ± 37.6</td></tr><tr><td>Triglycerides (mg/dL)</td><td>124.5 (88.0, 158.5)</td><td>109.0 (87.5, 147.3)</td><td>132.2 ± 47.5</td></tr><tr><td>HDL-c (mg/dL)</td><td>54.2 ± 14.5</td><td>48.0 ± 12.1</td><td>58.1 ± 14.6</td></tr><tr><td>LDLc (mg/dL)</td><td>98.4 ± 32.7</td><td>95.0 ± 31.3</td><td>100.5 ± 33.6</td></tr><tr><td>TNF-alpha (pg/mL)</td><td>4.6 (3.8, 5.8)</td><td>4.9 (3.7, 5.9)</td><td>4.6 (3.8, 5.8)</td></tr><tr><td>hsCRP (mg/L)</td><td>3.0 (1.7, 6.2)</td><td>2.3 (1.2, 3.6)</td><td>4.1 (2.1, 7.5)</td></tr><tr><td>IL-6 (pg/mL)</td><td>2.1 (1.4, 3.2)</td><td>1.7 (1.3, 3.0)</td><td>2.2 (1.6, 3.3)</td></tr><tr><td>Average SBP (mmHg)</td><td>130.7 ± 13.8</td><td>133.0 ± 13.1</td><td>129.3 ± 14.1</td></tr><tr><td>Average DBP (mmHg)</td><td>76.0 ± 7.9</td><td>76.4 ± 8.3</td><td>75.8 ± 7.6</td></tr><tr><td>Adiponectin (μg/mL)</td><td>8.76 (5.92, 13.84)</td><td>6.82 (5.06, 11.64)</td><td>10.09 (6.62, 15.79)</td></tr><tr><td>Leptin (ng/mL)</td><td>41.68 ± 20.24</td><td>22.97 (15.94, 29.27)</td><td>52.66 ± 16.10</td></tr><tr><td>AL ratio</td><td>0.23 (0.15, 0.45)</td><td>0.33 (0.21, 0.61)</td><td>0.19 (0.12, 0.29)</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean ± SD or median (25th percentile, 75th percentile).</p><p><italic>BMI</italic> body mass index, <italic>WC</italic> waist circumference, <italic>IAAT</italic> intra-abdominal adipose tissue determined by magnetic resonance imaging (MRI), <italic>SAAT</italic> subcutaneous abdominal adipose tissue determined by MRI, <italic>Tot Ab volume</italic> total abdominal fat volume determined by MRI, <italic>DXA total fat tissue</italic> percent total fat tissue determined by dual-energy X-ray absorptiometry (DXA), <italic>DXA trunk fat tissue</italic> percent trunk fat tissue determined by DXA, <italic>HDL-c</italic> high-density lipoprotein cholesterol, <italic>LDL-c</italic> low-density lipoprotein cholesterol, <italic>TNF-α</italic> tumor necrosis factor-alpha, <italic>hsCRP</italic> high sensitivity C-reactive protein, <italic>IL-6</italic> interleukin-6, <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>AL ratio</italic> adiponectin:leptin ratio, <italic>N</italic> sample size.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec9">
                <title>Characterizing the relationship between AL ratio and measures of cardiometabolic health at baseline</title>
                <p id="Par19">Among males, significant inverse correlations between AL ratio and BMI, WC, DXA percent total fat tissue, and DXA percent trunk fat tissue were observed at baseline (<italic>r</italic> = −0.357, <italic>p</italic> = 0.004; <italic>r</italic> = −0.259, <italic>p</italic> = 0.044, <italic>r</italic> = −0.268, <italic>p</italic> = 0.035; <italic>r</italic> = −0.342, <italic>p</italic> = 0.007, respectively). Among females, AL ratio was significantly inversely correlated with BMI, WC, subcutaneous abdominal adipose tissue, and total abdominal fat volume (<italic>r</italic> = −0.471, <italic>p</italic> &lt; 0.001; <italic>r</italic> = −0.385, <italic>p</italic> &lt; 0.001, <italic>r</italic> = −0.226, <italic>p</italic> = 0.026; <italic>r</italic> = −0.293, <italic>p</italic> = 0.003, respectively).</p>
                <p id="Par20">For cardiometabolic biomarkers, a significant inverse correlation was only detected between AL ratio and insulin among males (<italic>r</italic> = −0.542, <italic>p</italic> &lt; 0.001). Whereas among females, significant correlations between AL ratio and insulin, high-density lipoprotein cholesterol (HDL-c), hsCRP, and IL-6 were observed (<italic>r</italic> = −0.571, <italic>p</italic> &lt; 0.001; <italic>r</italic> = 0.395, <italic>p</italic> &lt; 0.001; <italic>r</italic> = −0.328, <italic>p</italic> = 0.001; <italic>r</italic> = −0.258, <italic>p</italic> = 0.010, respectively). A summary of baseline correlations is presented in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Bivariate Spearman’s correlation analyses between AL ratio and measures of adiposity and cardiometabolic health at baseline among older adults with obesity following a 12-month exercise and diet intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Males</th><th colspan="2">Females</th></tr><tr><th>Variable</th><th><italic>r</italic></th><th><italic>p</italic>-value<break/><italic>n</italic></th><th><italic>r</italic></th><th><italic>p</italic>-value<break/><italic>n</italic></th></tr></thead><tbody><tr><td>BMI (kg/m<sup>2</sup>)</td><td>−0.357**</td><td><p><italic>p</italic> = 0.004</p><p><italic>n</italic> = 62</p></td><td>−0.471***</td><td><p><italic>p</italic> &lt; 0.001</p><p><italic>n</italic> = 100</p></td></tr><tr><td>WC (in)</td><td>−0.259*</td><td><p><italic>p</italic> = 0.044</p><p><italic>n</italic> = 61</p></td><td>−0.385***</td><td><p><italic>p</italic> &lt; 0.001</p><p><italic>n</italic> = 100</p></td></tr><tr><td>IAAT (cm<sup>3</sup>)</td><td>−0.171</td><td><p><italic>p</italic> = 0.207</p><p><italic>n</italic> = 56</p></td><td>−0.181</td><td><p><italic>p</italic> = 0.074</p><p><italic>n</italic> = 98</p></td></tr><tr><td>SAAT (cm<sup>3</sup>)</td><td>−0.062</td><td><p><italic>p</italic> = 0.653</p><p><italic>n</italic> = 55</p></td><td>−0.226*</td><td><p><italic>p</italic> = 0.026</p><p><italic>n</italic> = 98</p></td></tr><tr><td>Tot Ab volume (cm<sup>3</sup>)</td><td>−0.181</td><td><p><italic>p</italic> = 0.181</p><p><italic>n</italic> = 56</p></td><td>−0.293**</td><td><p><italic>p</italic> = 0.003</p><p><italic>n</italic> = 98</p></td></tr><tr><td>DXA total fat tissue (%)</td><td>−0.268*</td><td><p><italic>p</italic> = 0.035</p><p><italic>n</italic> = 62</p></td><td>−0.074</td><td><p><italic>p</italic> = 0.470</p><p><italic>n</italic> = 98</p></td></tr><tr><td>DXA trunk fat tissue (%)</td><td>−0.342**</td><td><p><italic>p</italic> = 0.007</p><p><italic>n</italic> = 62</p></td><td>−0.138</td><td><p><italic>p</italic> = 0.176</p><p><italic>n</italic> = 98</p></td></tr><tr><td>Insulin (μU/mL)</td><td>−0.542***</td><td><p><italic>p</italic> &lt; 0.001</p><p><italic>n</italic> = 62</p></td><td>−0.571***</td><td><p><italic>p</italic> &lt; 0.001</p><p><italic>n</italic> = 100</p></td></tr><tr><td>Glucose (mg/dL)</td><td>−0.076</td><td><p><italic>p</italic> = 0.558</p><p><italic>n</italic> = 62</p></td><td>−0.131</td><td><p><italic>p</italic> = 0.194</p><p><italic>n</italic> = 100</p></td></tr><tr><td>Triglycerides (mg/dL)</td><td>−0.178</td><td><p><italic>p</italic> = 0.166</p><p><italic>n</italic> = 62</p></td><td>−0.060</td><td><p><italic>p</italic> = 0.554</p><p><italic>n</italic> = 100</p></td></tr><tr><td>Cholesterol (mg/dL)</td><td>−0.059</td><td><p><italic>p</italic> = 0.649</p><p><italic>n</italic> = 62</p></td><td>0.072</td><td><p><italic>p</italic> = 0.475</p><p><italic>n</italic> = 100</p></td></tr><tr><td>HDL-c (mg/dL)</td><td>0.119</td><td><p><italic>p</italic> = 0.357</p><p><italic>n</italic> = 62</p></td><td>0.395***</td><td><p><italic>p</italic> &lt; 0.001</p><p><italic>n</italic> = 100</p></td></tr><tr><td>LDL-c (mg/dL)</td><td>−0.087</td><td><p><italic>p</italic> = 0.506</p><p><italic>n</italic> = 61</p></td><td>−0.046</td><td><p><italic>p</italic> = 0.652</p><p><italic>n</italic> = 100</p></td></tr><tr><td>TNF-α (pg/mL)</td><td>−0.158</td><td><p><italic>p</italic> = 0.220</p><p><italic>n</italic> = 62</p></td><td>−0.171</td><td><p><italic>p</italic> = 0.089</p><p><italic>n</italic> = 100</p></td></tr><tr><td>hsCRP (mg/L)</td><td>−0.247</td><td><p><italic>p</italic> = 0.053</p><p><italic>n</italic> = 62</p></td><td>−0.328**</td><td><p><italic>p</italic> = 0.001</p><p><italic>n</italic> = 99</p></td></tr><tr><td>IL-6 (pg/mL)</td><td>0.069</td><td><p><italic>p</italic> = 0.592</p><p><italic>n</italic> = 62</p></td><td>−0.258*</td><td><p><italic>p</italic> = 0.010</p><p><italic>n</italic> = 99</p></td></tr><tr><td>Average SBP (mmHg)</td><td>−0.062</td><td><p><italic>p</italic> = 0.634</p><p><italic>n</italic> = 62</p></td><td>0.074</td><td><p><italic>p</italic> = 0.464</p><p><italic>n</italic> = 100</p></td></tr><tr><td>Average DBP (mmHg)</td><td>0.014</td><td><p><italic>p</italic> = 0.915</p><p><italic>n</italic> = 62</p></td><td>−0.041</td><td><p><italic>p</italic> = 0.687</p><p><italic>n</italic> = 100</p></td></tr></tbody></table><table-wrap-foot><p><italic>AL ratio</italic> adiponectin:leptin ratio, <italic>BMI</italic> body mass index, <italic>WC</italic> waist circumference, <italic>IAAT</italic> intra-abdominal adipose tissue determined by magnetic resonance imaging (MRI), <italic>SAAT</italic> subcutaneous adipose tissue determined by MRI; <italic>Tot Ab volume</italic> total abdominal fat volume determined by MRI; <italic>DXA Total fat tissue</italic> percent total fat tissue determined by dual-energy X-ray absorptiometry (DXA), <italic>DXA trunk fat tissue</italic> percent trunk fat tissue determined by DXA, <italic>HDL-c</italic> high-density lipoprotein cholesterol, <italic>LDL-c</italic> low-density lipoprotein cholesterol, <italic>TNF-α</italic> tumor necrosis factor-alpha, <italic>hsCRP</italic> high sensitivity C-reactive protein, <italic>IL-6</italic> interleukin-6, <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>r</italic> correlation coefficient, <italic>n</italic> sample size.</p><p>*<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, and ***<italic>p</italic> &lt; 0.001.</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec10">
                <title>Changes in AL ratio following a 12-month exercise and diet intervention</title>
                <p id="Par21">Generalized linear mixed model results are presented in Table <xref rid="Tab3" ref-type="table">3</xref>. A significant time effect was observed such that AL ratio significantly increased among all participants from baseline to study completion (<italic>F</italic> (1,140 = 40.89, <italic>p</italic> &lt; 0.001). There was also a significant biological sex effect (F (1,157) = 50.98, <italic>p</italic> &lt; 0.001), as well as a significant intervention group by biological sex interaction effect (<italic>F</italic> (2,157) = 4.44, <italic>p</italic> = 0.013). Among the total sample and by intervention groups, males consistently exhibited a significantly higher AL ratio than females (Supplemental Table <xref rid="MOESM1" ref-type="media">1</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>AL ratio as a function of intervention group, biological sex, and time among older adults with obesity following a 12-month exercise and diet intervention.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Effect</th><th><italic>df</italic></th><th>F</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td colspan="4"><italic>Main effects</italic></td></tr><tr><td>Intervention</td><td>2,157</td><td>3.42</td><td>0.035</td></tr><tr><td>Time</td><td>1,140</td><td>40.89</td><td>&lt;.0001</td></tr><tr><td>Biological sex</td><td>1,157</td><td>50.98</td><td>&lt;.0001</td></tr><tr><td colspan="4"><italic>Interaction effects</italic></td></tr><tr><td>Intervention × biological sex</td><td>2,157</td><td>4.44</td><td>0.013</td></tr><tr><td>Intervention × time</td><td>2,140</td><td>21.32</td><td>&lt;.0001</td></tr><tr><td>Biological sex × time</td><td>1,140</td><td>5.84</td><td>0.017</td></tr><tr><td>Intervention × biological sex × time</td><td>2,140</td><td>0.58</td><td>0.563</td></tr></tbody></table><table-wrap-foot><p>Generalized linear mixed model results to evaluate the intervention effects on the AL ratio. Statistical significance defined as <italic>p</italic> &lt; 0.05.</p><p><italic>AL</italic><italic>ratio</italic> adiponectin:leptin ratio.</p></table-wrap-foot></table-wrap></p>
                <p id="Par22">There were no significant differences in AL ratio among intervention groups at baseline. A significant time by intervention group interaction effect was observed (<italic>F</italic> (2,140 = 21.32, <italic>p</italic> &lt; 0.001). Analysis of simple main effects revealed that the AL ratio significantly increased from baseline to study completion among participants in the exercise + weight maintenance group (baseline adjusted mean: 0.327, 12-month adjusted mean: 0.361; <italic>p</italic> = 0.027) and exercise + weight loss group (baseline adjusted mean: 0.357, 12-month adjusted mean: 0.511; <italic>p</italic> &lt;0.001). Improvements in AL ratio were correlated with changes in adiposity measures, notably, intra-abdominal adipose tissue levels (weight loss: <italic>r</italic> = −0.620, <italic>p</italic> &lt; 0.001), total abdominal fat volume (weight maintenance: <italic>r</italic> = −0.323, <italic>p</italic> = 0.033; weight loss: <italic>r</italic> = −0.456, <italic>p</italic> = 0.002), and DXA percent trunk fat tissue (weight maintenance: <italic>r</italic> = −0.405, <italic>p</italic> = 0.006; weight loss: <italic>r</italic> = −0.423, <italic>p</italic> = 0.003). Despite improvements, the magnitude of changes differed such that the exercise + weight loss group exhibited a significantly greater AL ratio at study completion compared to the exercise + weight maintenance group (<italic>p</italic> &lt; 0.001) and exercise only group (<italic>p</italic> = 0.004).</p>
              </sec>
            </sec>
            <sec id="Sec11" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par23">Obesity-associated alterations in adipokine concentrations, namely leptin and adiponectin, underpin the development of adipose tissue dysfunction, thus supporting an environment conducive to cardiometabolic disease [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The purpose of this ancillary study was to investigate the relationship between the AL ratio, an emerging biomarker of adipose tissue dysfunction, and cardiometabolic health among older adults with obesity following a 12-month exercise and diet intervention</p>
              <p id="Par24">Previous research has consistently supported the relationship between AL ratio and cardiometabolic health among diverse populations including Korean, Japanese, Hispanic, and Slovenian adults [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR25">25</xref>]. However, to our knowledge, this is the first study investigating the AL ratio in a biracial population of older adults. Results demonstrated that among older adults with obesity, the AL ratio was significantly associated with measures of adiposity and cardiometabolic health at baseline. In particular, correlations were observed between this ratio and BMI, WC, and measures of fat mass, as well as insulin, HDL-c, and inflammatory biomarkers. The inverse correlations related to adiposity suggest that the conventional obesity-associated alterations in adipokine secretion are captured by the AL ratio in this unique population. Similar correlations between AL ratio and body composition have been reported in Japanese adults with and without diabetes, as well as generally healthy Korean and Chinese adults [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
              <p id="Par25">Results from the current study also support the AL ratio as a measure of adipose tissue dysfunction in the older adult population. For example, inverse correlations between this ratio and inflammatory biomarkers and insulin levels were observed, as well as a positive correlation with HDL-c. A surplus of circulating leptin nullifies its anorexigenic effects while concurrently amplifying its pro-inflammatory properties through increased activation of the nuclear factor kappa B (NFkB) signaling cascade [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Furthermore, reductions in adiponectin inhibit signaling pathways to combat inflammation, thus perpetuating the pro-inflammatory response observed in obesity [<xref ref-type="bibr" rid="CR6">6</xref>]. Previous research has also established a link between the AL ratio and inflammatory biomarkers, namely hsCRP and serum amyloid A (SAA), among Caucasian adults with and without metabolic syndrome [<xref ref-type="bibr" rid="CR28">28</xref>]. Although SAA was not evaluated in the current study, this protein has been shown to increase proportionally with adiposity levels and to be responsive to weight loss interventions [<xref ref-type="bibr" rid="CR29">29</xref>]. Accordingly, its incorporation into future investigations of the AL ratio and cardiometabolic health is warranted.</p>
              <p id="Par26">The relationship between AL ratio and insulin levels is likely driven by adiponectin. The binding of adiponectin to receptors in the liver and skeletal muscle activates signaling molecules like AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (p38 MAPK) thereby regulating glucose metabolism and insulin sensitivity [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Zalatel et al. reported that the AL ratio was significantly associated with the euglycemic clamp-derived sensitivity index, a gold standard of insulin sensitivity assessment, and was also superior to other measures of insulin resistance, including homeostatic model assessment of insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI) index [<xref ref-type="bibr" rid="CR11">11</xref>]. Strong correlations between the AL ratio and insulin levels have also been highlighted in Asian populations with and without hyperglycemia [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].</p>
              <p id="Par27">Interestingly, among the lipids assessed, a significant correlation was only observed between AL ratio and HDL-c. The directionality of this relationship remains under investigation, but it is proposed that increased HDL-c enhances adiponectin secretion from adipose tissue, supporting its anti-inflammatory and insulin-sensitizing roles [<xref ref-type="bibr" rid="CR30">30</xref>]. Nonetheless, similar relationships between the AL ratio and HDL-c have been reported [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Although previous research has not established a significant link between this ratio and LDL-c, there have been reports of an inverse correlation between AL ratio and TG levels [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Such findings were not observed in the current study and may be related to a limited power to detect associations.</p>
              <p id="Par28">Acknowledging the differences in adipose tissue biology between males and females, it is suggested that biological sex be taken into account when investigating adiposity and cardiometabolic health [<xref ref-type="bibr" rid="CR31">31</xref>]. The current study substantiates such recommendations, as males had a significantly higher AL ratio than females, irrespective of timing or intervention. Similar differences have been reported, albeit limited, and have been ascribed to inherent alterations in adipokine secretion between biological sexes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In general, circulating leptin levels tend to be higher among females with and without obesity compared to their male counterparts [<xref ref-type="bibr" rid="CR32">32</xref>]. This is attributed, in part, to an increased rate of leptin secretion per unit mass of adipose tissue in females, as well as an influence of sex hormones on the release of adipokines [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. While additional mechanisms underpinning this discrepancy remain to be fully elucidated, results from the current study suggest that the AL ratio may be more sensitive to change among males.</p>
              <p id="Par29">There are a limited number of studies investigating the sensitivity of AL ratio to lifestyle interventions, and the few that exist were conducted among adolescents. For example, Masquio et al. enrolled adolescents with and without metabolic syndrome into a one-year study investigating the effects of combined nutrition and physical activity intervention on cardiometabolic health [<xref ref-type="bibr" rid="CR34">34</xref>]. Both groups (no metabolic syndrome vs. overt metabolic syndrome) experienced an improvement in AL ratio that was associated with increases in omega-3 fatty acid consumption. Ferreira et al. implemented a non-intensive interdisciplinary therapy consisting of nutrition and exercise modifications among adolescents with obesity for 20 weeks [<xref ref-type="bibr" rid="CR35">35</xref>]. In contrast to the first study, a significant increase in AL ratio was only observed among participants who lost &gt;5% of body weight. While this magnitude of weight loss is generally accepted among the studied population, there is greater controversy surrounding such recommendations for older adults [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Accordingly, the CROSSROADS parent study implemented a moderate weight loss intervention based upon recommendations outlined in a Position Statement by the American Society for Nutrition and The Obesity Society [<xref ref-type="bibr" rid="CR18">18</xref>]. Adherence to this intervention resulted in a significant 4.1% reduction in body weight with preservation of lean body mass and bone mineral density [<xref ref-type="bibr" rid="CR16">16</xref>]. Given the modest body weight changes observed in the current study compared to that achieved by Ferreira et al., it was unclear whether the AL ratio would be altered to a similar degree [<xref ref-type="bibr" rid="CR35">35</xref>]. Nonetheless, the significant treatment effect observed in the current study demonstrates how each lifestyle intervention under investigation resulted in modification of the AL ratio to varying extents among older adults with obesity.</p>
              <p id="Par30">Despite overall improvements, expanded analysis of the interaction effects revealed that only participants in the exercise + weight maintenance group and exercise + weight loss group exhibited a significant increase in AL ratio from baseline to 12 months. Thus, while physical activity may influence adipokine secretion, results suggest that its benefits are amplified when combined with improvements in dietary quality and a caloric restriction of 500 kcal/d.</p>
              <p id="Par31">It is noteworthy that AL ratio benefits were observed in the exercise + weight maintenance group, as this underscores the importance of simple dietary modifications for the older adult population. Previous research suggests that certain nutrients, namely omega-3 fatty acids and fiber, may favorably alter the AL ratio [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Although the purpose of this study was not to tease apart the individual dietary components associated with AL ratio changes, the results support how general improvements in dietary quality can have a meaningful impact on cardiometabolic health independent of weight loss. As such, recommendations to increase the consumption of fruit and non-starchy vegetables should not be underestimated by health care providers [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
              <p id="Par32">Though physical activity and dietary modifications may influence adipokine secretion, results from the current study suggest that an exercise + weight loss intervention is optimal for improved AL ratio in a community-dwelling older adult population with obesity. This is not unexpected, as weight loss is related to the restoration of balance in adiponectin and leptin levels, therefore supporting an increase in the AL ratio. These results, paired with the retention of lean body mass and bone mineral density, highlight the value of a comprehensive weight loss plan including a moderate caloric reduction and robust exercise program comprised of aerobic and resistance training.</p>
              <sec id="Sec12">
                <title>Strengths and limitations</title>
                <p id="Par33">Strengths of this study include robust outcome measures, notably the evaluation of visceral adipose tissue, as well as the rigorous design and monitoring of adherence in the parent study. This is also the first study to characterize the AL ratio as a measure of adipose tissue dysfunction and to evaluate its sensitivity to lifestyle interventions in a biracial older adult population. This study provides insightful results for future research, yet it is not exempt from some limitations. For example, this exploratory study was ancillary to a randomized controlled trial that was not specifically powered to detect the outcomes of this study, thus potentially obscuring some relationships. As such, an expanded investigation is warranted to discern potential differences in sensitivity of the AL ratio to lifestyle interventions by biological sex. Additionally, to enhance generalizability, it would be advantageous to evaluate the AL ratio among a greater number of Caucasian and African American older adults from various regions of the United States.</p>
              </sec>
            </sec>
            <sec id="Sec13" sec-type="conclusion">
              <title>Conclusions</title>
              <p id="Par34">Taken collectively, correlations between AL ratio and measures of cardiometabolic health support its application as a biomarker of adipose tissue dysfunction in the older adult population. The AL ratio may be clinically useful in identifying individuals susceptible to cardiometabolic disease such that a low AL ratio is reflective of dysfunctional adipose tissue and the need for intervention prior to over disease onset. Furthermore, results suggest that a 12-month exercise and diet intervention with intentional weight loss is optimal for improving the AL ratio among community-dwelling older adults with obesity. The addition of this ratio to future studies may strengthen obesity research.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary information</title>
              <sec id="Sec14">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41387_2022_207_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplemental Table 1. Adjusted AL ratio means among older adults with obesity following a 12- month exercise and diet intervention.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary information</title>
              <p>The online version contains supplementary material available at 10.1038/s41387-022-00207-1.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>The parent CROSSROADS Randomized Controlled Trial was supported by the National Institute on Aging at the National Institutes of Health (research grant R01AG033094).</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>The authors confirm contribution to the paper as follows: analysis and interpretation of the data: KES, KMCW, and ACB; the drafting of the paper: KES, KMCW, and ACB; revising it critically for intellectual content: KES, KMCW, JLL, and JDA; and the final approval of the version to be published: KES, KMCW, ACB, JLL, and JDA. All authors agree to be accountable for all aspects of the work.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>The data that support the findings of this study are available from the corresponding author, KMCW, upon reasonable request.</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par35">The authors declare no competing interests.</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hruby</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>FB</given-names>
                    </name>
                  </person-group>
                  <article-title>The epidemiology of obesity: a big picture</article-title>
                  <source>Pharmacoeconomics.</source>
                  <year>2015</year>
                  <volume>33</volume>
                  <fpage>673</fpage>
                  <lpage>89</lpage>
                  <pub-id pub-id-type="doi">10.1007/s40273-014-0243-x</pub-id>
                  <pub-id pub-id-type="pmid">25471927</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Poirier</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Giles</surname>
                      <given-names>TD</given-names>
                    </name>
                    <name>
                      <surname>Bray</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>Hong</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Stern</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Pi-Sunyer</surname>
                      <given-names>FX</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism</article-title>
                  <source>Circulation.</source>
                  <year>2006</year>
                  <volume>113</volume>
                  <fpage>898</fpage>
                  <lpage>918</lpage>
                  <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.171016</pub-id>
                  <pub-id pub-id-type="pmid">16380542</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Deng</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Scherer</surname>
                      <given-names>PE</given-names>
                    </name>
                  </person-group>
                  <article-title>Adipokines as novel biomarkers and regulators of the metabolic syndrome</article-title>
                  <source>Ann N Y Acad Sci</source>
                  <year>2010</year>
                  <volume>1212</volume>
                  <fpage>E1</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05875.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Francisco</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Pino</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gonzalez‐Gay</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Mera</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lago</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Gómez</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adipokines and inflammation: is it a question of weight?</article-title>
                  <source>Br J Pharm</source>
                  <year>2018</year>
                  <volume>175</volume>
                  <fpage>1569</fpage>
                  <lpage>79.</lpage>
                  <pub-id pub-id-type="doi">10.1111/bph.14181</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <mixed-citation publication-type="other">Fantuzzi G. Adipokines: Leptin and adiponectin in the regulation of inflammatory and immune responses. In: Fantuzzi G, Braunschweigh C, editors. Adipose tissue and adipokines in health and disease. 2nd ed. Springer; 2014. p. 81–90.</mixed-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ouchi</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Adiponectin as an anti-inflammatory factor</article-title>
                  <source>Clin Chim Acta</source>
                  <year>2007</year>
                  <volume>380</volume>
                  <fpage>24</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cca.2007.01.026</pub-id>
                  <pub-id pub-id-type="pmid">17343838</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lihn</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pedersen</surname>
                      <given-names>SB</given-names>
                    </name>
                    <name>
                      <surname>Richelsen</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Adiponectin: action, regulation and association to insulin sensitivity</article-title>
                  <source>Obes Rev</source>
                  <year>2005</year>
                  <volume>6</volume>
                  <fpage>13</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1467-789X.2005.00159.x</pub-id>
                  <pub-id pub-id-type="pmid">15655035</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ouchi</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Parker</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Lugus</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Adipokines in inflammation and metabolic disease</article-title>
                  <source>Nat Rev Immunol</source>
                  <year>2011</year>
                  <volume>11</volume>
                  <fpage>85</fpage>
                  <lpage>97</lpage>
                  <pub-id pub-id-type="doi">10.1038/nri2921</pub-id>
                  <pub-id pub-id-type="pmid">21252989</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zorena</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Jachimowicz-Duda</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Ślęzak</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Robakowska</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mrugacz</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Adipokines and obesity. Potential link to metabolic disorders and chronic complications</article-title>
                  <source>Int J Mol Sci</source>
                  <year>2020</year>
                  <volume>21</volume>
                  <fpage>3570</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijms21103570</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Inoue</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maehata</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Yano</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Taniyama</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes</article-title>
                  <source>Metabolism</source>
                  <year>2005</year>
                  <volume>54</volume>
                  <fpage>281</fpage>
                  <lpage>6</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.metabol.2004.09.006</pub-id>
                  <pub-id pub-id-type="pmid">15736103</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zaletel</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Barlovic</surname>
                      <given-names>DP</given-names>
                    </name>
                    <name>
                      <surname>Prezelj</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with type 2 diabetes</article-title>
                  <source>J Endocrinol Invest</source>
                  <year>2010</year>
                  <volume>33</volume>
                  <fpage>514</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF03346639</pub-id>
                  <pub-id pub-id-type="pmid">20142631</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frühbeck</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Catalán</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Rodríguez</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ramírez</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Becerril</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Salvador</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation</article-title>
                  <source>Nutrients.</source>
                  <year>2019</year>
                  <volume>11</volume>
                  <fpage>454</fpage>
                  <lpage>67</lpage>
                  <pub-id pub-id-type="doi">10.3390/nu11020454</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Satoh</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Naruse</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Usui</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tagami</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Suganami</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Yamada</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients</article-title>
                  <source>Diabetes Care</source>
                  <year>2004</year>
                  <volume>27</volume>
                  <fpage>2488</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="doi">10.2337/diacare.27.10.2488</pub-id>
                  <pub-id pub-id-type="pmid">15451921</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vega</surname>
                      <given-names>GL</given-names>
                    </name>
                    <name>
                      <surname>Grundy</surname>
                      <given-names>SM</given-names>
                    </name>
                  </person-group>
                  <article-title>Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio</article-title>
                  <source>J Obes</source>
                  <year>2013</year>
                  <volume>2013</volume>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1155/2013/409679</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frühbeck</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Catalán</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Rodríguez</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gómez-Ambrosi</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk</article-title>
                  <source>Adipocyte</source>
                  <year>2018</year>
                  <volume>7</volume>
                  <fpage>57</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="doi">10.1080/21623945.2017.1402151</pub-id>
                  <pub-id pub-id-type="pmid">29205099</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ard</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Gower</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Hunter</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Ritchie</surname>
                      <given-names>CS</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Goss</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of calorie restriction in obese older adults: The CROSSROADS randomized controlled trial</article-title>
                  <source>J Gerontol A Biol Sci Med</source>
                  <year>2018</year>
                  <volume>73</volume>
                  <fpage>73</fpage>
                  <lpage>80</lpage>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Weinsier</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Bacon</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Birch</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Time-calorie displacement diet for weight control: A prospective evaluation of its adequacy for maintaining normal nutritional status</article-title>
                  <source>Int J Obes</source>
                  <year>1983</year>
                  <volume>7</volume>
                  <fpage>539</fpage>
                  <lpage>48</lpage>
                  <?supplied-pmid 6654571?>
                  <pub-id pub-id-type="pmid">6654571</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Villareal</surname>
                      <given-names>DT</given-names>
                    </name>
                    <name>
                      <surname>Apovian</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Kushner</surname>
                      <given-names>RF</given-names>
                    </name>
                    <name>
                      <surname>Klein</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity in older adults: technical review and position statement of the American Society for nutrition and NAASO, the obesity society</article-title>
                  <source>Am J Clin Nutr</source>
                  <year>2005</year>
                  <volume>82</volume>
                  <fpage>923</fpage>
                  <lpage>34</lpage>
                  <pub-id pub-id-type="doi">10.1093/ajcn/82.5.923</pub-id>
                  <pub-id pub-id-type="pmid">16280421</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harnack</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Stevens</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Van Heel</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Schakel</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dwyer</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Himes</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls</article-title>
                  <source>J Food Compost Anal</source>
                  <year>2008</year>
                  <volume>21</volume>
                  <fpage>S78</fpage>
                  <lpage>82</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jfca.2007.05.004</pub-id>
                  <pub-id pub-id-type="pmid">19190705</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haas</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Bodner</surname>
                      <given-names>EV</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <name>
                      <surname>Bryan</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Buys</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Keita</surname>
                      <given-names>AD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Calorie restriction in overweight seniors: response of older adults to a dieting study: the CROSSROADS randomized controlled clinical trial</article-title>
                  <source>J Nutr Gerontol Geriatr</source>
                  <year>2014</year>
                  <volume>33</volume>
                  <fpage>376</fpage>
                  <lpage>400</lpage>
                  <pub-id pub-id-type="doi">10.1080/21551197.2014.965993</pub-id>
                  <pub-id pub-id-type="pmid">25424512</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jaccard</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Becker</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Wood</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Pairwise multiple comparison procedures: a review</article-title>
                  <source>Psychol Bull</source>
                  <year>1984</year>
                  <volume>96</volume>
                  <fpage>589</fpage>
                  <pub-id pub-id-type="doi">10.1037/0033-2909.96.3.589</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jung</surname>
                      <given-names>C-H</given-names>
                    </name>
                    <name>
                      <surname>Rhee</surname>
                      <given-names>E-J</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>J-H</given-names>
                    </name>
                    <name>
                      <surname>Bae</surname>
                      <given-names>J-C</given-names>
                    </name>
                    <name>
                      <surname>Yoo</surname>
                      <given-names>S-H</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>W-J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy Korean male adults</article-title>
                  <source>Korean Diabetes J.</source>
                  <year>2010</year>
                  <volume>34</volume>
                  <fpage>237</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.4093/kdj.2010.34.4.237</pub-id>
                  <pub-id pub-id-type="pmid">20835341</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Inoue</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yano</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Yamakado</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maehata</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia</article-title>
                  <source>Metabolism.</source>
                  <year>2006</year>
                  <volume>55</volume>
                  <fpage>1248</fpage>
                  <lpage>54</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.metabol.2006.05.010</pub-id>
                  <pub-id pub-id-type="pmid">16919546</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Oda</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Imamura</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Fujita</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Uchida</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Inagaki</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kakizawa</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The ratio of leptin to adiponectin can be used as an index of insulin resistance</article-title>
                  <source>Metabolism.</source>
                  <year>2008</year>
                  <volume>57</volume>
                  <fpage>268</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.metabol.2007.09.011</pub-id>
                  <pub-id pub-id-type="pmid">18191059</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mirza</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Qu</surname>
                      <given-names>H-Q</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Martinez</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Rentfro</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>McCormick</surname>
                      <given-names>JB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adiponectin/leptin ratio and metabolic syndrome in a Mexican American population</article-title>
                  <source>Clin Invest Med</source>
                  <year>2011</year>
                  <volume>34</volume>
                  <fpage>E290</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.25011/cim.v34i5.15672</pub-id>
                  <pub-id pub-id-type="pmid">21968271</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cross-sectional associations of adipokines and abdominal fat distribution with aging in men</article-title>
                  <source>Aging Male</source>
                  <year>2020</year>
                  <volume>23</volume>
                  <fpage>1576</fpage>
                  <lpage>82.</lpage>
                  <pub-id pub-id-type="doi">10.1080/13685538.2021.1876020</pub-id>
                  <pub-id pub-id-type="pmid">33499713</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pérez-Pérez</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sánchez-Jiménez</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Vilariño-García</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Sánchez-Margalet</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of leptin in inflammation and vice versa</article-title>
                  <source>Int J Mol Sci</source>
                  <year>2020</year>
                  <volume>21</volume>
                  <fpage>5887</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijms21165887</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Frühbeck</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Catalán</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Rodríguez</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ramírez</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Becerril</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Salvador</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome</article-title>
                  <source>Sci Rep.</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-016-0028-x</pub-id>
                  <pub-id pub-id-type="pmid">28127051</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gómez-Ambrosi</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Salvador</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rotellar</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Silva</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Catalán</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Rodríguez</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass</article-title>
                  <source>Obes Surg</source>
                  <year>2006</year>
                  <volume>16</volume>
                  <fpage>262</fpage>
                  <lpage>9</lpage>
                  <pub-id pub-id-type="doi">10.1381/096089206776116525</pub-id>
                  <pub-id pub-id-type="pmid">16545156</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Interaction between adipocytes and high-density lipoprotein: new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis</article-title>
                  <source>Lipids Health Dis</source>
                  <year>2019</year>
                  <volume>18</volume>
                  <fpage>1</fpage>
                  <lpage>11.</lpage>
                  <pub-id pub-id-type="doi">10.1186/s12944-018-0950-y</pub-id>
                  <pub-id pub-id-type="pmid">30611256</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Varghese</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Singer</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Gender and sex differences in adipose tissue</article-title>
                  <source>Curr Diab Rep.</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11892-018-1031-3</pub-id>
                  <pub-id pub-id-type="pmid">29362940</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Isidori</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Strollo</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Morè</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Caprio</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Aversa</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Moretti</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <year>2000</year>
                  <volume>85</volume>
                  <fpage>1954</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="doi">10.1210/jcem.85.5.6572</pub-id>
                  <pub-id pub-id-type="pmid">10843181</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hellström</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Wahrenberg</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Hruska</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Reynisdottir</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Arner</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms behind gender differences in circulating leptin levels</article-title>
                  <source>J Intern Med</source>
                  <year>2000</year>
                  <volume>247</volume>
                  <fpage>457</fpage>
                  <lpage>62</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1365-2796.2000.00678.x</pub-id>
                  <pub-id pub-id-type="pmid">10792559</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Masquio</surname>
                      <given-names>DC</given-names>
                    </name>
                    <name>
                      <surname>de Piano</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sanches</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Corgosinho</surname>
                      <given-names>FC</given-names>
                    </name>
                    <name>
                      <surname>Campos</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Carnier</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effect of weight loss magnitude on pro‐/anti‐inflammatory adipokines and carotid intima–media thickness in obese adolescents engaged in interdisciplinary weight loss therapy</article-title>
                  <source>Clin Endocrinol</source>
                  <year>2013</year>
                  <volume>79</volume>
                  <fpage>55</fpage>
                  <lpage>64</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1365-2265.2012.04504.x</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferreira</surname>
                      <given-names>YAM</given-names>
                    </name>
                    <name>
                      <surname>Kravchychyn</surname>
                      <given-names>ACP</given-names>
                    </name>
                    <name>
                      <surname>Vicente</surname>
                      <given-names>SDCF</given-names>
                    </name>
                    <name>
                      <surname>da Silveira Campos</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Tock</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Oyama</surname>
                      <given-names>LM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Influence of magnitude of weight loss on Adipo/lep ratio in adolescents with obesity undergoing multicomponent therapy</article-title>
                  <source>Cytokine.</source>
                  <year>2020</year>
                  <volume>131</volume>
                  <fpage>155111</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.cyto.2020.155111</pub-id>
                  <pub-id pub-id-type="pmid">32371378</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>August</surname>
                      <given-names>GP</given-names>
                    </name>
                    <name>
                      <surname>Caprio</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Fennoy</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Freemark</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Kaufman</surname>
                      <given-names>FR</given-names>
                    </name>
                    <name>
                      <surname>Lustig</surname>
                      <given-names>RH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <year>2008</year>
                  <volume>93</volume>
                  <fpage>4576</fpage>
                  <lpage>99</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2007-2458</pub-id>
                  <pub-id pub-id-type="pmid">18782869</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Waters</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Ward</surname>
                      <given-names>AL</given-names>
                    </name>
                    <name>
                      <surname>Villareal</surname>
                      <given-names>DT</given-names>
                    </name>
                  </person-group>
                  <article-title>Weight loss in obese adults 65 years and older: a review of the controversy</article-title>
                  <source>Exp Gerontol</source>
                  <year>2013</year>
                  <volume>48</volume>
                  <fpage>1054</fpage>
                  <lpage>61</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.exger.2013.02.005</pub-id>
                  <pub-id pub-id-type="pmid">23403042</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cleary</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Ray</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rogozina</surname>
                      <given-names>OP</given-names>
                    </name>
                    <name>
                      <surname>Dogan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Grossmann</surname>
                      <given-names>ME</given-names>
                    </name>
                  </person-group>
                  <article-title>Targeting the adiponectin: leptin ratio for postmenopausal breast cancer prevention</article-title>
                  <source>Front Biosci</source>
                  <year>2009</year>
                  <volume>1</volume>
                  <fpage>329</fpage>
                  <lpage>57</lpage>
                  <pub-id pub-id-type="doi">10.2741/s30</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
